Erlotinib-Related Spontaneous Pneumothorax in Patient with Primary Lung Cancer / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 465-468, 2010.
Article
Dans En
| WPRIM
| ID: wpr-214078
Responsable en Bibliothèque :
WPRO
ABSTRACT
Spontaneous pneumothorax (SPTx) associated with primary lung cancer is quite rare, but has been reported as the initial presentation or a complication of disease progression. Moreover, chemotherapy-related SPTx in primary lung cancer occurs at a very low frequency, accounting for less than 0.05% of all cases. Here, we report the first case of erlotinib-related SPTx in a patient with advanced lung adenocarcinoma in Korea. After 3 cycles of cisplatin-based chemotherapy as first-line therapy, erlotinib was administered as second-line treatment. Asymptomatic SPTx accompanied by a significant decrease in tumor size was observed in the left lung 7 weeks later. The patient received continuous administration of erlotinib, without additional treatment. This case showed that SPTx can occur in patients with primary lung cancer receiving erlotinib, and asymptomatic chemotherapy-related SPTx in primary lung cancer may not require therapeutic intervention.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Pneumothorax
/
Quinazolines
/
Adénocarcinome
/
Évolution de la maladie
/
Chlorhydrate d'erlotinib
/
Comptabilité
/
Corée
/
Poumon
/
Tumeurs du poumon
Limites du sujet:
Humans
Pays comme sujet:
Asia
langue:
En
Texte intégral:
Tuberculosis and Respiratory Diseases
Année:
2010
Type:
Article